重庆医学Issue(21)：2720-2721,2724,3.DOI:10.3969/j.issn.1671-8348.2014.21.011
替罗非班联合瑞替普酶在ST 段抬高性急性心肌梗死中的疗效观察
Effect of tirofiban combined with reteplase in patients with ST segment elevation acute myocardial infarction
戴树人 1李芝峰 1廖荣宏 1李晓丽 1高崇瀚 1杨爽 1陈紫君1
作者信息
- 1. 重庆医科大学附属永川医院心内科 402160
- 折叠
摘要
Abstract
Objective To study the thrombolysis effect and safety of tirofiban combined with half dose reteplase in patients with ST segment elevation acute myocardial infarction .Methods 60 patients with ST segment elevation acute myocardial infarction in our hospital from January 2011 to March 2013 were selected as research object ,and they were divided into reteplase group (control group ,n=32) and tirofiban combined with reteplase group (observation group ,n=28) ,then the recanalization rate of infarct-relat-ed artery at different time and incidence of complications were compared .Results The recanalization rate of infarct-related artery of observation group at different time were all higher than those of control group (P<0 .05) ,while incidence of complications of two groups had no significant difference(P>0 .05) .Conclusion The thrombolysis effect of tirofiban combined with half dose reteplase in patients with ST segment elevation acute myocardial infarction is better ,and it does not increase the incidence of complications .关键词
替罗非班/瑞替普酶/ST段抬高性急性心肌梗死/溶栓/并发症Key words
tirofiban/reteplase/ST segment elevation acute myocardial infarction/thrombolysis/complication分类
医药卫生引用本文复制引用
戴树人,李芝峰,廖荣宏,李晓丽,高崇瀚,杨爽,陈紫君..替罗非班联合瑞替普酶在ST 段抬高性急性心肌梗死中的疗效观察[J].重庆医学,2014,(21):2720-2721,2724,3.
